Treatment of progressive supranuclear palsy with methysergide. A clinical study

Springer Science and Business Media LLC - Tập 12 - Trang 157-161 - 1991
G. Di Trapani1, P. Stampatore1, A. La Cara1, A. Azzoni1, M. L. Vaccario1
1Istituto di Neurologia, Università Cattolica del S. Cuore, Roma

Tóm tắt

We present a clinical study of a patient aged 69 years with a clinical history of severe difficulty in walking and voluntary conjugate eye movement reduction in sideways glance and absence in vertical gaze. These symptoms led to diagnosis of Parkison disease and treatment with L-Dopa+anticholinergics drugs. The treatment with antiparkinsonian drugs was suspended and no change in his clinical condition resulted. Methysergide therapy was initiated and the patient's response was monitored by video recording. On the basis of our experience and the data reported in the literature we believe that methysergide therapy affords some relief of symptoms in patients suffering from PSP.

Tài liệu tham khảo

Behrman S., Carroll J.D., Janota I., Matthews W.B.:Progressive supranuclear palsy: a clinico-pathological study of four cases. Brain 92: 663–678, 1969. Brusa A., Mancardi G.L., Bugiani O.:Progressive supranuclear palsy 1979: an overview. Ital. J. Neurol. Sci. 1: 205–222, 1980. Ducombe A.S., Lees A.J.:Methysergide in progressive supranuclear palsy. Neurology 35: 936, 1985. Haldeman S., Goldman J.W., Hyde J., Pribram H.F.W.:Progressive supranuclear palsy, computed tomography and response to antiparkinsonian drugs. Neurology 31: 442–445, 1981. Jackson J.A., Jankovich J., Ford J.:Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann. Neurol. 13: 273–278, 1983. Jankovich J.:Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy. Neurology 33: 505–507, 1983. Kvale J.N.:Amitriptyline in the management of progressive supranuclear palsy. Arch. Neurol. 39: 387–388, 1982. Lees A.J., Haddad S., Show K.M., Kohout L.J., Stern G.M.:Bromocriptine in Parkinsonism. Arch. Neurol. 35: 503–505, 1978 Neophytides A., Lieberman A.N., Goldstein M., et al.:The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. J. Neurol. Neuosurg. Psychiatry 45: 261–263, 1982 Newman G.C.:Treatment of progressive supranuclear palsy with tricyclic antidepressant. Neurology 35: 1189–1193, 1985 Paulson G.W., Lowery H.W., Taylor G.C.:Progressive supranuclear palsy: pneumoencephalography, electronystagmography and treatment with methysergide. Eur. Neurol. 20: 13–16, 1981. Perret J.L., Jouvet M.:Etude du sommeil dans la paralysie supra-nucleaire progressive. Electroencephalogr. Clin. Neurophysiol. 49: 323–329, 1980. Rafal R.D., Grimm R.J.:Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents. Neurology 31: 1507–1518, 1981. Steele J.C., Richardson J.C., Olszewski J.:Progressive supranuclear palsy. Arch. Neurol. 10: 333–359, 1964.